by PEPID Newsroom | Jul 10, 2019 | Alerts
According to the NutriNet-Sante prospective cohort study of 101,257 participants with the mean age of 42 and a medium follow-up of 5 years, sugary drinks like soda and fruit juices show a significant association of risk of overall cancer, and breast cancer....
by PEPID Newsroom | May 24, 2019 | Alerts
Pigray (alpelisib) tablets have been FDA approved to treat breast cancer in combination with FDA-approved endocrine therapy fulvestrant. Pigray is approved for postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2...
by PEPID Newsroom | Apr 16, 2019 | Alerts
The American College of Physicians (ACP) issued new guidance statements on breast cancer screening for asymptomatic women of average-risk. This issue follows a thorough review and inclusion of the following existing guidelines and associated evidence: American...
